India's Hetero wins emergency use nod to make Roche's Covid drug
PremiumIndian drug developer Hetero said that it has received emergency use approval to make a generic version of Roche Holding AG's COVID-19 drug
PremiumBENGALURU: Indian drug developer Hetero said on Monday that it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
MINT PREMIUM
See All
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.
Never miss a story! Stay connected and informed with Mint. Download our App Now!!
